Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol

INTRODUCTION: Although the only curative strategy for pancreatic cancer is surgical resection, up to 85% of patients relapse after surgery. The efficacy of neoadjuvant treatment in resectable pancreatic cancer (RPC) remains unclear and there is no systematic review focusing fully on this issue. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong-chan, Ahn, Soyeon, Paik, Kyu-hyun, Kim, Hyoung Woo, Kang, Jingu, Kim, Jaihwan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809107/
https://www.ncbi.nlm.nih.gov/pubmed/27016245
http://dx.doi.org/10.1136/bmjopen-2015-010491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809107/
https://www.ncbi.nlm.nih.gov/pubmed/27016245
http://dx.doi.org/10.1136/bmjopen-2015-010491

Ejemplares similares